BERGER FRANKLIN M

Director at Seagen Inc. · on record since May 19, 2006
Director at Diadexus, Inc. · on record since Feb 15, 2007
Director at Rain Oncology Inc. · on record since Apr 27, 2021
Director at EMISPHERE TECHNOLOGIES INC · on record since May 19, 2009
Director at Kezar Life Sciences, Inc. · on record since May 11, 2026
Director at Lineage Cell Therapeutics, Inc. · on record since May 23, 2013
Director at Asterias Biotherapeutics, Inc. · on record since Sep 27, 2013
Director at FIVE PRIME THERAPEUTICS, INC. · on record since Sep 17, 2013
Director at IMMUNE DESIGN CORP. · on record since Jul 31, 2014
Director at KINETA, INC./DE · on record since Feb 17, 2016
Director at Forte Biosciences, Inc. · on record since Apr 21, 2017
Director at Atreca, Inc. · on record since Jun 24, 2019
Director at Atea Pharmaceuticals, Inc. · on record since Oct 30, 2020
Director at ESSA Pharma Inc. · on record since Oct 1, 2020

Insider trading activity of BERGER FRANKLIN M

Transactions on record: 259; since Dec 22, 2003

Open-market buys: 47; $15.2M

Open-market sells: 13; $2.6M

Companies traded: 13; last filing Jun 23, 2026

Figures computed from official regulatory filings — .

Companies where BERGER FRANKLIN M has traded

Atea Pharmaceuticals, Inc.31 tx · $2.4M · Jun 23, 2026
Kezar Life Sciences, Inc.33 tx · $3.1M · May 11, 2026
ESSA Pharma Inc.26 tx · $3M · Oct 15, 2025
17 tx · $3.4M · Jan 26, 2024
8 tx · Jun 15, 2023
36 tx · $2.4M · Apr 19, 2021
13 tx · $2.1M · Jul 1, 2020
5 tx · $253.4K · Oct 4, 2019
14 tx · $2.2M · Apr 4, 2019
68 tx · $3.5M · Feb 25, 2014
2 tx · $1.9K · Aug 22, 2013
2 tx · May 19, 2009
4 tx · $331.9K · Jun 11, 2008

Track record of BERGER FRANKLIN M

Statistical track record

Free account

Open-market buys: 47

Last buy: Jan 16, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BERGER FRANKLIN M

Co-insiders of BERGER FRANKLIN M

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	AwardD (derivative)	26,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	Exercise	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	ExerciseD (derivative)	-29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	AwardD (derivative)	37,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-2,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	Other	-89,069	—	n/a (No price was disclosed in the filing)		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-2,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Oct 15, 2025	Other	-784,404	—	n/a (No price was disclosed in the filing)		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	ExerciseD (derivative)	-29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	Exercise	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	41,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 23, 2025	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	10,000	3.36 USD	$33.6K	conv 28	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	15,000	3.19 USD	$47.9K	conv 35First in 12mo	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	-15,000	3.19 USD	$47.9K	conv 44First in 12mo	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	-10,000	3.36 USD	$33.6K	conv 35	SEC
Atea Pharmaceuticals, Inc.Listing on record	Dec 12, 2024	Sell	-359,606	2.85 USD	$1M	Unusual size	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 21, 2024	AwardD (derivative)	41,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 21, 2024	AwardD (derivative)	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 21, 2024	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 18, 2024	ExerciseD (derivative)	-33,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	AwardD (derivative)	26,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	Exercise	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	ExerciseD (derivative)	-29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	AwardD (derivative)	37,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-2,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	Other	-89,069	—	n/a (No price was disclosed in the filing)		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	May 11, 2026	OtherD (derivative)	-2,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Oct 15, 2025	Other	-784,404	—	n/a (No price was disclosed in the filing)		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	ExerciseD (derivative)	-29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	Exercise	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	41,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 23, 2025	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	10,000	3.36 USD	$33.6K	conv 28	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	15,000	3.19 USD	$47.9K	conv 35First in 12mo	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	-15,000	3.19 USD	$47.9K	conv 44First in 12mo	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jan 17, 2025	Buy	-10,000	3.36 USD	$33.6K	conv 35	SEC
Atea Pharmaceuticals, Inc.Listing on record	Dec 12, 2024	Sell	-359,606	2.85 USD	$1M	Unusual size	SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 21, 2024	AwardD (derivative)	41,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 21, 2024	AwardD (derivative)	29,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 21, 2024	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atea Pharmaceuticals, Inc.Listing on record	Jun 18, 2024	ExerciseD (derivative)	-33,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC